Literature DB >> 32473772

Case for diagnosis. Pruritic erythematosquamous lesion in the auricle.

Elaine Dias Melo1, Patrícia Motta de Morais2, Débora Cristina de Lima Fernandes3, Paula Frassinetti Bessa Rebello4.   

Abstract

Chromoblastomycosis is a subcutaneous mycosis with chronic evolution that mainly affects the lower limbs and, less frequently, the auricles. Clinically, it presents with papillary verrucous, nodular, and/or tumoral lesions, whether isolated or infiltrated, forming plaques and, sometimes, atrophic in some areas. Histopathologically, it is characterized by a dermal granulomatous inflammatory infiltrate, and the diagnosis can be confirmed by the presence of fumagoid bodies in anatomopathological or direct mycological exams. The treatment to be indicated will depend on the extent and location of the lesions, using systemic antifungals, surgical removal, cryotherapy, thermotherapy, and immunoadjuvants. The present study reports an atypical presentation of chromoblastomycosis on the auricle.
Copyright © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Auricle; Chromoblastomycosis; Ear, external; Mycosis

Mesh:

Substances:

Year:  2020        PMID: 32473772      PMCID: PMC7335870          DOI: 10.1016/j.abd.2019.11.011

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


Case report

A 57-year-old male farmer presented a pruritic lesion on the left auricle, with 20 years of evolution. He did not recall local trauma at the onset of the condition. Upon examination, an infiltrated, erythematosquamous lesion was observed on the left ear. The histopathological examination presented a granulomatous inflammatory infiltrate with suppurative foci (Fig. 1A and B).
Figure 1

(A and B) Erythematous, infiltrative lesion in the left ear. Histopathological examination: granulomatous inflammatory infiltrate with suppurative foci (Hematoxylin & eosin, ×400).

(A and B) Erythematous, infiltrative lesion in the left ear. Histopathological examination: granulomatous inflammatory infiltrate with suppurative foci (Hematoxylin & eosin, ×400). What is your diagnosis? Jorge Lobo's disease Sarcoidosis Paracoccidioidomycosis Chromoblastomycosis The review of the sections for histopathological examination evidenced the presence of fumagoid bodies, compatible with chromoblastomycosis. In the direct examination of biopsy fragments in 20% KOH, septate demaceous hyphae and isolated yeast cells in pairs were observed, as well as some gemmule structures. In culture, on Mycosel agar (DIFCO®) and Sabouraud dextrose agar (DIFCO®) with chloramphenicol (0.05 g/L), a blackened colony growth was observed; in microculture, phenotypic findings compatible with Rhinocladiella sp. were observed (Fig. 2 A and B).
Figure 2

(A and B) Direct examination: fumagoid bodies. Microculture: septate demaceous hyphae and elliptical conidia in the upper portion of simple or slightly branched conidiophores – phenotypic characteristics compatible with Rhinocladiella spp. (KOH-20%, ×400; blue, lactophenol, ×400).

(A and B) Direct examination: fumagoid bodies. Microculture: septate demaceous hyphae and elliptical conidia in the upper portion of simple or slightly branched conidiophores – phenotypic characteristics compatible with Rhinocladiella spp. (KOH-20%, ×400; blue, lactophenol, ×400). R. aquaspersa was confirmed through amplification and sequencing of the intergenic spacer (ITS) region of the ribosomal DNA (rDNA) using the polymerase chain reaction (PCR) technique. After confirmation of the diagnosis of chromoblastomycosis, itraconazole (300 mg/day) was initiated; the patient presented significant improvement after 25 days and almost complete remission in ten weeks (Fig. 3 A and B). The patient remains under outpatient follow-up.
Figure 3

(A and B) After 25 days of treatment, and at the end of ten weeks.

(A and B) After 25 days of treatment, and at the end of ten weeks.

Discussion

Chromoblastomycosis is a subcutaneous mycosis caused by demaceous fungi of the order Chaetothyriales, family Herpotrichiellaceae, found in decomposing soil, vegetables, plants, and wood.1, 2 The main etiological agents are from the genera Fonsecaea, Cladophialophora, Phialophora, Rhinocladiella, and Exophiala. Inoculation occurs after trauma with contaminated material.1, 3, 4 The condition most frequently affects men between 40 and 50 years of age, being considered a cosmopolitan disease, with greater prevalence in tropical and subtropical regions. In Brazil, it occurs in most states, with a predominance in the Amazon region, particularly in the state of Pará.2, 5 The disease mainly affects the lower limbs. In cases with long evolution, association with lymphedema is common.1, 4, 6 In Japan, the most common locations involved are the upper limbs, face, and cervical region. Reports of manifestations exclusively on the auricle are rare.1, 3, 6, 7, 8, 9, 10 Among the cases reported in this topography, Fonsecaea pedrosoi1, 3, 10 and Phialophora verrucosa were the most commonly identified agents, followed by Fonsecaea nubica and Rhinocladiella aquaspersa. According to the literature consulted, this is the second case with isolated involvement of the auricle caused by R. aquaspersa. In the Amazon region, the differential diagnosis must include Jorge Lobo's disease, leprosy, anergic leishmaniasis, cutaneous tuberculosis, and paracoccidioidomycosis. Histopathological and mycological exams are essential for diagnosis. Several treatments are indicated for chromoblastomycosis. For localized lesions, surgical excision, cryotherapy, or thermotherapy are recommended; for more extensive cases, systemic and immunoadjuvant antifungals are recommended.2, 4 Among systemic antifungals, itraconazole, posaconazole, voriconazole, and isavuconazole are used. The literature reports two cases of chromoblastomycosis in auricular locations, which presented complete regression after treatment with flucytosine and itraconazole for 12 and 10 weeks, respectively. There are reports of a good therapeutic response with the association of systemic antifungals and topical immunoadjuvants, such as imiquimod.

Financial support

None declared.

Authors’ contributions

Elaine Dias Melo: Conception and planning of the study; elaboration and writing of the manuscript; obtaining, analyzing, and interpreting the data; intellectual participation in propaedeutic and/or therapeutic conduct of studied cases; critical review of the literature. Patrícia Motta de Morais: Approval of the final version of the manuscript; intellectual participation in propaedeutic and/or therapeutic conduct of studied cases; critical review of the literature; critical review of the manuscript. Débora Cristina de Lima Fernandes: Elaboration and writing of the manuscript; critical review of the literature. Paula Frassinetti Bessa Rebello: Approval of the final version of the manuscript; intellectual participation in propaedeutic and/or therapeutic conduct of studied cases.

Conflicts of interest

None declared.
  10 in total

1.  Deep mycoses in Amazon region.

Authors:  S Talhari; M G Cunha; A P Schettini; A C Talhari
Journal:  Int J Dermatol       Date:  1988-09       Impact factor: 2.736

Review 2.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil.

Authors:  R Minotto; C D Bernardi; L F Mallmann; M I Edelweiss; M L Scroferneker
Journal:  J Am Acad Dermatol       Date:  2001-04       Impact factor: 11.527

4.  [Chromomycosis: report of a case with unusual topography].

Authors:  Víctor Fernando Muñoz Estrada; Greys Anaid Valenzuela Paz; Mariana Rochín Tolosa
Journal:  Rev Iberoam Micol       Date:  2010-12-15       Impact factor: 1.044

5.  Auricular chromoblastomycosis: a case report and review of published literature.

Authors:  Katlein França; Ricardo Tadeu Villa; Viviane Reis de Azevedo Bastos; Ana Carolina C Almeida; Katyane Massucatti; Daniella Fukumaru; Valcinir Bedin
Journal:  Mycopathologia       Date:  2011-02-17       Impact factor: 2.574

6.  Auricular chromomycosis.

Authors:  T Iwatsu; M Takano; S Okamoto
Journal:  Arch Dermatol       Date:  1983-01

7.  A case of chromoblastomycosis by Fonsecaea nubica indicating a possible insect route of transmission.

Authors:  Yingdan Chen; Songchao Yin; Meirong Li; Rongzhang Chen; Ling Wei; Han Ma; Shuwen Deng; Gert Sybren de Hoog; Wei Lai; Chun Lu; Peiying Feng
Journal:  Mycoses       Date:  2016-06-22       Impact factor: 4.377

8.  Auricular chromoblastomycosis caused by Rhinocladiella aquaspersa.

Authors:  M Arango; C Jaramillo; A Cortés; A Restrepo
Journal:  Med Mycol       Date:  1998-02       Impact factor: 4.076

9.  [Auricular chromoblastomycosis. A case report].

Authors:  A L Bittencourt; A T Londero; J A Andrade
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1994 Jul-Aug       Impact factor: 1.846

Review 10.  Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.

Authors:  Arival Cardoso de Brito; Maraya de Jesus Semblano Bittencourt
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.